Lpl Financial LLC Tg Therapeutics, Inc. Transaction History

Lpl Financial LLC

$218 Billion
Q3 2024

A detailed history of Lpl Financial LLC transactions in Tg Therapeutics, Inc. stock. As of the latest transaction made, Lpl Financial LLC holds 114,322 shares of TGTX stock, worth $3.38 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

114,322

Previous 133,280 14.22%

Holding current value

$3.38 Million

Previous $2.37 Million 12.74%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 08, 2024	SELL	$17.21 - $25.28 $326,267 - $479,258	-18,958 Reduced 14.22%	114,322 $2.67 Million
Q2 2024 Aug 07, 2024	BUY	$13.32 - $19.19 $250,122 - $360,349	18,778 Added 16.4%	133,280 $2.37 Million
Q1 2024 May 10, 2024	BUY	$13.02 - $21.3 $285,580 - $467,194	21,934 Added 23.7%	114,502 $1.74 Million
Q4 2023 Feb 14, 2024	BUY	$6.68 - $18.81 $7,882 - $22,195	1,180 Added 1.29%	92,568 $1.58 Million
Q3 2023 Nov 13, 2023	BUY	$8.36 - $26.5 $202,562 - $642,095	24,230 Added 36.08%	91,388 $764,000
Q2 2023 Jul 31, 2023	BUY	$15.48 - $35.0 $263,314 - $595,350	17,010 Added 33.92%	67,158 $1.67 Million
Q1 2023 May 10, 2023	BUY	$10.23 - $19.34 $115,527 - $218,406	11,293 Added 29.06%	50,148 $754,000
Q4 2022 Feb 07, 2023	BUY	$5.01 - $11.83 $57,514 - $135,808	11,480 Added 41.94%	38,855 $459,000
Q3 2022 Nov 14, 2022	SELL	$4.57 - $8.4 $5,781 - $10,626	-1,265 Reduced 4.42%	27,375 $162,000
Q2 2022 Aug 12, 2022	SELL	$3.74 - $10.66 $4,809 - $13,708	-1,286 Reduced 4.3%	28,640 $122,000
Q1 2022 May 16, 2022	BUY	$7.81 - $20.45 $20,555 - $53,824	2,632 Added 9.64%	29,926 $285,000
Q4 2021 Feb 14, 2022	BUY	$15.2 - $35.51 $7,007 - $16,370	461 Added 1.72%	27,294 $519,000
Q3 2021 Nov 15, 2021	BUY	$21.78 - $40.45 $162,827 - $302,404	7,476 Added 38.62%	26,833 $893,000
Q2 2021 Aug 13, 2021	BUY	$32.5 - $48.96 $257,042 - $387,224	7,909 Added 69.09%	19,357 $751,000
Q1 2021 May 14, 2021	SELL	$41.61 - $54.3 $371,826 - $485,224	-8,936 Reduced 43.84%	11,448 $552,000
Q4 2020 Feb 12, 2021	BUY	$25.27 - $54.9 $151,594 - $329,345	5,999 Added 41.7%	20,384 $1.06 Million
Q3 2020 Nov 09, 2020	BUY	$18.49 - $27.24 $1,497 - $2,206	81 Added 0.57%	14,385 $385,000
Q2 2020 Aug 13, 2020	BUY	$8.9 - $21.84 $8,766 - $21,512	985 Added 7.4%	14,304 $279,000
Q1 2020 May 14, 2020	SELL	$7.14 - $15.99 $4,833 - $10,825	-677 Reduced 4.84%	13,319 $131,000
Q4 2019 Feb 14, 2020	BUY	$5.1 - $11.2 $11,388 - $25,009	2,233 Added 18.98%	13,996 $155,000
Q3 2019 Nov 13, 2019	SELL	$5.38 - $8.99 $941 - $1,573	-175 Reduced 1.47%	11,763 $66,000
Q2 2019 Aug 09, 2019	BUY	$6.27 - $8.65 $1,937 - $2,672	309 Added 2.66%	11,938 $103,000
Q1 2019 May 08, 2019	SELL	$4.02 - $8.04 $1,137 - $2,275	-283 Reduced 2.38%	11,629 $93,000
Q4 2018 Feb 07, 2019	BUY	$3.44 - $5.76 $40,977 - $68,613	11,912 New	11,912 $49,000

Others Institutions Holding TGTX

# of Institutions

338

Shares Held

88.3M

Call Options Held

2.35M

Put Options Held

1.7M

View Full List

About TG THERAPEUTICS, INC.

Ticker TGTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 145,274,000
Market Cap $4.29B
Description
TG Therapeutics, Inc., a commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell malignancies and autoimmune diseases. Its therapeutic product candidates include Ublituximab, an investigational glycoengineered monoclonal antibody for the treatment of B-cell non-hod...

More about TGTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Lpl Financial LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lpl Financial LLC with notifications on news.

Account

Lpl Financial LLC Tg Therapeutics, Inc. Transaction History